This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Oncothyreon: A Failed Drug Autopsy Performed By A Short Seller

Fund manager Martin Shkreli offers advice on how to avoid the next Oncothyreon blowup.

Nektar Therapeutics Is a Short
Nektar Therapeutics Is a Short

09/12/12 - 07:08 AM EDT

Investor Martin Shkreli believes Nektar's constipation drug is a bust and the stock is a good short.

Page 1 of 1
< Previous
Next >
Top Rated Stocks Top Rated Funds Top Rated ETFs